Sage Rhino Capital’s Biogen BIIB Stock Holding History

Sage Rhino Capital’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-760	Closed	-$215K	–	229
2021 Q3	$215K	Sell	760 -3	-0.4%	-$983	0.07%	183
2021 Q2	$264K	Buy	763 +12	+2%	+$3.63K	0.08%	163
2021 Q1	$210K	Buy	+751	New	+$203K	0.07%	167
2020 Q4	–	Sell	-784	Closed	-$222K	–	179
2020 Q3	$222K	Sell	784 -7	-0.9%	-$1.95K	0.11%	138
2020 Q2	$212K	Sell	791 -13	-2%	-$3.91K	0.11%	139
2020 Q1	$254K	Buy	804 +7	+0.9%	+$2.12K	0.18%	101
2019 Q4	$236K	Buy	+797	New	+$221K	0.13%	128

Other funds holding BIIB

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Sage Rhino Capital's BIIB Position: Q4 2021 in Review

Sage Rhino Capital sold out of Biogen (BIIB) in Q4 2021, closing a stake of 760 shares — an estimated $215K sold.

Sage Rhino Capital first reported a position in BIIB in Q4 2019 and held it in 7 quarters. The position peaked at $264K in Q2 2021. 1,009 funds tracked by Wall St. Rank hold BIIB as of Q4 2021.

Sage Rhino Capital reported no remaining Biogen position as of Q4 2021 after selling out during the quarter.
Sage Rhino Capital sold 760 Biogen shares in Q4 2021, an estimated $215K.
Sage Rhino Capital first reported a position in Biogen in Q4 2019 and held it in 7 quarters.
Sage Rhino Capital's Biogen position peaked at $264K in Q2 2021.
1,009 funds tracked by Wall St. Rank held Biogen as of Q4 2021.

Based on Sage Rhino Capital's 13F filing for Q4 2021, filed 4 Feb 2022.